- The purpose of this study is to to prove that the long-term efficacy of strategy of
treatment adjustment at W24 according to virological response based on ROADMAP concept
is better than standard of care strategy.
- To evaluate the off-treatment durability of HBeAg seroconversion in patients who
discontinued treatment due to sustained HBeAg seroconversion and HBV DNA<300copies/ml
with over 12 months consolidation treatment
Phase:
Phase 4
Details
Lead Sponsor:
Nanfang Hospital of Southern Medical University
Collaborators:
Major Science and Technology Special Project of China Eleventh Five-year Novartis